COVID-19
Showing NaN - NaN of 49
SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)
Recruiting
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- +4 more
-
Athens, Alabama
- +158 more
Jul 18, 2022
COVID-19, SARS-CoV-2 Trial in Puerto Rico, United States (Abatacept, Placebo)
Terminated
- COVID-19
- SARS-CoV-2
- Abatacept
- Placebo
-
Hialeah, Florida
- +9 more
Jul 6, 2022
Subsequent and Co-infections Associated With SARS-CoV-2
Completed
- COVID-19
- Observational
-
Dallas, TexasMethodist Dallas Medical Center
May 24, 2022
COVID-19 Breakthrough Infection in Fully Vaccinated People and
Enrolling by invitation
- COVID-19 Pneumonia
- COVID-19
- Pfizer COVID-19 mRNA vaccine
- Moderna COVID-19 mRNA vaccine
-
Dallas, TexasMethodist Dallas Medical Center
May 24, 2022
COVID, COVID-19, SARS-CoV-2 Trial in Worldwide (biological, other, drug)
Completed
- COVID
- +3 more
- Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)
- +2 more
-
Colorado Springs, Colorado
- +38 more
Mar 31, 2022
COVID-19 Vaccine Response in Sickle Cell Disease
Recruiting
- Sickle Cell Disease
- COVID-19
- COVID-19 Vaccine
-
Washington, District of Columbia
- +5 more
Dec 2, 2021
COVID-19 Trial in Dallas (Experimental Group, Placebo Group)
Completed
- COVID-19
- Experimental Group
- Placebo Group
-
Dallas, TexasUniversity of Texas Medical Center
Dec 12, 2021
COVID-19, SARS-CoV 2 Trial in United States (Hydroxychloroquine (HCQ), Azithromycin (Azithro), Placebo for Hydroxychloroquine)
Terminated
- COVID-19
- SARS-CoV 2
- Hydroxychloroquine (HCQ)
- +3 more
-
Birmingham, Alabama
- +10 more
Nov 12, 2021
Methodist Health System COVID-19 Patient Registry
Recruiting
- COVID-19
- Treatment for COVID-19
-
Dallas, TexasClinical Research Institute Methodist Health System
Nov 9, 2021
Cardiovascular Manifestations of COVID-19
Recruiting
- COVID-19
- Chart review
-
Dallas, TexasMethodist Dallas Medical Center
Nov 9, 2021
Corona Virus Infection, Covid19, COVID-19 Trial in Worldwide (Awake Proning)
Completed
- Corona Virus Infection
- +2 more
- Awake Proning
-
Dallas, Texas
- +16 more
Oct 14, 2021
COVID-19 Trial in United States (Hydroxychloroquine, Placebo oral tablet)
COVID-19 Trial in Dallas (Hydroxychloroquine)
Completed
- COVID-19
-
Dallas, TexasBaylor University Medical Center
Aug 18, 2021
Predictors of Severe COVID-19 Outcomes
Active, not recruiting
- Acute Respiratory Distress Syndrome
- COVID-19
-
Tucson, Arizona
- +7 more
Aug 16, 2021